A
Akoya Biosciences Inc
NASDAQ:AKYA
Akoya Biosciences Inc
NASDAQ:AKYA
Price:
1.29
USD
Market Closed
Market Cap:
$64.4m
Cash Flow Statement
Cash Flow Statement
Akoya Biosciences Inc
Akoya Biosciences Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(17)
|
(23)
|
(24)
|
(31)
|
(43)
|
(51)
|
(63)
|
(69)
|
(71)
|
(73)
|
(76)
|
(71)
|
(63)
|
(68)
|
(60)
|
(58)
|
(55)
|
(48)
|
|
| Depreciation & Amortization |
4
|
4
|
4
|
4
|
5
|
5
|
6
|
7
|
7
|
8
|
8
|
9
|
9
|
9
|
9
|
8
|
8
|
7
|
|
| Change in Deffered Taxes |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
| Stock-Based Compensation |
0
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
7
|
8
|
9
|
10
|
10
|
11
|
11
|
10
|
0
|
(0)
|
|
| Other Non-Cash Items |
4
|
7
|
7
|
7
|
7
|
6
|
7
|
8
|
8
|
9
|
14
|
15
|
18
|
22
|
20
|
18
|
17
|
12
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
5
|
6
|
7
|
8
|
8
|
9
|
9
|
9
|
9
|
|
| Change in Working Capital |
2
|
1
|
(8)
|
(13)
|
(5)
|
(10)
|
0
|
6
|
2
|
1
|
1
|
(7)
|
(14)
|
(14)
|
(20)
|
(15)
|
(14)
|
(3)
|
|
| Cash from Operating Activities |
(7)
N/A
|
(10)
-50%
|
(21)
-101%
|
(32)
-56%
|
(36)
-11%
|
(50)
-38%
|
(51)
-2%
|
(49)
+2%
|
(54)
-8%
|
(55)
-3%
|
(54)
+3%
|
(55)
-3%
|
(51)
+8%
|
(52)
-2%
|
(51)
+1%
|
(47)
+9%
|
(44)
+6%
|
(30)
+31%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(8)
|
(7)
|
(7)
|
(7)
|
(4)
|
(4)
|
(4)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Other Items |
10
|
10
|
0
|
0
|
0
|
0
|
(41)
|
(30)
|
(7)
|
0
|
41
|
30
|
7
|
(48)
|
(39)
|
(25)
|
(22)
|
43
|
|
| Cash from Investing Activities |
7
N/A
|
7
+8%
|
7
-5%
|
6
-14%
|
(5)
N/A
|
(5)
-5%
|
(47)
-778%
|
(38)
+20%
|
(14)
+63%
|
(7)
+52%
|
34
N/A
|
26
-24%
|
3
-87%
|
(52)
N/A
|
(41)
+20%
|
(27)
+34%
|
(24)
+12%
|
41
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
49
|
49
|
48
|
48
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
10
|
10
|
10
|
10
|
(0)
|
(0)
|
10
|
19
|
31
|
31
|
21
|
11
|
11
|
11
|
11
|
11
|
(1)
|
(1)
|
|
| Other |
(4)
|
(2)
|
133
|
133
|
137
|
0
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Cash from Financing Activities |
5
N/A
|
8
+48%
|
143
+1 650%
|
143
0%
|
137
-4%
|
137
0%
|
9
-94%
|
19
+114%
|
29
+54%
|
28
-1%
|
66
+133%
|
56
-15%
|
57
+1%
|
57
0%
|
8
-85%
|
8
0%
|
(3)
N/A
|
(3)
+6%
|
|
| Change in Cash | |||||||||||||||||||
| Net Change in Cash |
5
N/A
|
5
-5%
|
129
+2 412%
|
116
-10%
|
96
-17%
|
82
-14%
|
(89)
N/A
|
(68)
+23%
|
(39)
+43%
|
(34)
+13%
|
46
N/A
|
27
-42%
|
9
-65%
|
(47)
N/A
|
(84)
-79%
|
(66)
+22%
|
(71)
-9%
|
7
N/A
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(10)
N/A
|
(13)
-29%
|
(24)
-83%
|
(37)
-53%
|
(41)
-13%
|
(55)
-33%
|
(57)
-3%
|
(57)
-1%
|
(61)
-6%
|
(62)
-2%
|
(61)
+3%
|
(59)
+2%
|
(55)
+8%
|
(56)
-2%
|
(54)
+4%
|
(49)
+9%
|
(47)
+4%
|
(32)
+31%
|
|
Switch to:
Switch to:
See Also
Discover More
